Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Antibodies are becoming a frontline therapy for SARS-CoV-2, but the risk of viral evolutionary escape remains unclear. Here we map how all mutations to SARS-CoV-2’s receptor-binding domain (RBD) affect binding by the antibodies in Regeneron’s REGN-COV2 cocktail and Eli Lilly’s LY-CoV016. These compl...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:bioRxiv
Auteurs principaux: Starr, Tyler N., Greaney, Allison J., Addetia, Amin, Hannon, William W., Choudhary, Manish C., Dingens, Adam S., Li, Jonathan Z., Bloom, Jesse D.
Format: Artigo
Langue:Inglês
Publié: Cold Spring Harbor Laboratory 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724661/
https://ncbi.nlm.nih.gov/pubmed/33299993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.11.30.405472
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires